The CTNNB1 mutaion as a prognostic marker of sporadic desmoid tumors with meloxicam
Not Applicable
Completed
- Conditions
- sporadic desmoid tumor
- Registration Number
- JPRN-UMIN000019321
- Lead Sponsor
- Department of Orthopaedic Surgery, Nagoya University Graduate School and School of Medicine
- Brief Summary
All 4 cases with S45F mutation showed PD, and no cases in favorable group (0/20 cases) had S45F mutation(p=0.017), whereas cases with T41A or wild type did not show significant association with efficacy of meloxicam.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 33
Inclusion Criteria
Not provided
Exclusion Criteria
familial adenomatous polyposis-associated desmoid tumor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method